Corbus Pharmaceuticals Holdings, Inc. (CRBP)
9.71
-0.43
(-4.24%)
USD |
NASDAQ |
Apr 07, 16:00
9.70
-0.01
(-0.10%)
After-Hours: 20:00
Corbus Pharmaceuticals Holdings EPS Diluted (Quarterly) : -1.247 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | -0.301 |
| Curis, Inc. | 1.229 |
| Plus Therapeutics, Inc. | -1.03 |
| Windtree Therapeutics, Inc. | -1.085 |
| Halozyme Therapeutics, Inc. | -1.203 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.56M |
| Total Expenses (Quarterly) | 20.56M |
| Enterprise Value | 9.915M |
| Earnings Yield | -64.36% |
| Normalized Earnings Yield | -64.36 |